Original Research: Local TAT-p27Kip1 Fusion protein inhibits cell proliferation in rat Carotid arteries

Therapeutic Advances in Cardiovascular Disease

Volumn 2, Issue 3, 2008, Pages 129-136

  Miyakawa, Ayumi A ^a   Krieger, Jose E ^a   Neukamm, Birgit ^a   Pacheco, Fernando P ^a   Fukada, Sandra Y ^a   Andrade, Claudia R ^a   Ramalho, Leandra N Z ^a   Oliveira, Ana Maria ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

P27Kip1; TAT Fusion Protein; Vascular Injury

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; EPITOPE; TRANSACTIVATOR PROTEIN; ANTIMITOTIC AGENT; COMPLEMENTARY DNA; DNA; GREEN FLUORESCENT PROTEIN; THYMIDINE; TRANSACTIVATOR PROTEIN CYCLIN DEPENDENT KINASE INHIBITOR 1B FUSION PROTEIN;

ANIMAL; AORTA; ARTICLE; CAROTID ARTERY; CAROTID ARTERY INJURY; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; ENDOTHELIUM CELL; MALE; PATHOLOGY; PHYSIOLOGY; RAT; VASCULAR ENDOTHELIUM; WISTAR RAT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; CELL MEMBRANE PERMEABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RABBIT;

ANIMALS; AORTA; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P27; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EPITOPES; GENE PRODUCTS, TAT; MALE; RATS; RATS, WISTAR;

EID: 59649086731     PISSN: 17539447     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753944708090170     Document Type: Article

References (25)

1. Becker-Hapak, M., McAllister, S.S. and Dowdy, S.F. (2001)TAT-mediated protein transduction into mammalian cells. Methods 24: 247-256. Review.
2. Besson, A., Gurian-West, M., Schmidt, A., Hall, A. and Roberts, J.M. (2004)p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 18: 862-876.
3. Buonassisi, V. and Venter, J.C. (1976)Hormone and neurotransmitter receptors in an established vascular endothelial cell line. Proc Nat Acad Sci USA 73: 1612-1616.
4. Chen, D., Krasinski, K., Sylvester, A., Chen, J., Nisen, P.D. and Andres, V. (1997)Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery. J Clin Invest 99: 2334-2341.
5. Console, S., Marty, C., Garcia-Echeverria, C., Schwendener, R. and Ballmer-Hofer, K. (2003)Antennapedia and HIV transactivator of transcription (TAT) “protein transduction domains” promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J Biol Chem 278: 35109-35114.
6. Del Gaizo Moore, V. and Payne, R.M. (2004)Transactivator of transcription fusion protein transduction causes membrane inversion. J Biol Chem 279: 32541-32544.
7. Diez-Juan, A. and Andres, V. (2003)Coordinate control of proliferation and migration by the p27Kip1/cyclin-dependent kinase / retinoblastoma pathway in vascular smooth muscle cells and fibroblasts. Circ Res 92: 402-410.
8. Fukada, S.Y., Correa, F.M., Ramalho, L.N., Mizusaki, C.I. and de Oliveira, A.M. (2004)
9. Perivascular injury leads to a reduction in vascular reactivity of the collared and to an enhancement on contralateral carotid artery of rats. Cardiovasc Pathol 13: 251-259.
10. Futaki, S. (2002)Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int J Pharm 245: 1-7. Review.
11. Gallo, R., Padurean, A., Jayaraman, T., Marx, S., Roque, M., Adelman, S.et al. (1999)Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 99: 2164-2170.
12. Goukassian, D., Diez-Juan, A., Asahara, T., Schratzberger, P., Silver, M., Murayama, T.et al. (2001)Overexpression of p27(Kip1) by doxycycline-regulated adenoviral vectors inhibits endothelial cell proliferation and migration and impairs angiogenesis. FASEB J 15: 1877-1885.
13. Ihling, C., Technau, K., Gross, V., Schulte-Monting, J., Zeiher, A.M. and Schaefer, H.E. (1999)Concordant upregulation of type II-TGFbeta-receptor, the cyclin-dependent kinases inhibitor P27Kip1 and cyclin E in human atherosclerotic tissue: implications for lesion cellularity. Atherosclerosis 144: 7-14.
14. Kilic, U., Kilic, E., Dietz, G.P. and Bahr, M. (2003)Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice. Stroke 34: 1304-1310.
15. Lundberg, M., Wikstrom, S. and Johansson, M. (2003)Cell surface adherence and endocytosis of protein transduction domains. Mol Ther 8: 143-150.
16. McAllister, S.S., Becker-Hapak, M., Pintucci, G., Pagano, M. and Dowdy, S.F. (2003)Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions. Mol Cell Biol 23: 216-228.
17. Nagahara, H., Vocero-Akbani, A.M., Snyder, E.L., Ho, A., Latham, D.G., Lissy, N.A.et al. (1998)Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med 4: 1449-1452.
18. Schwarze, S.R., Ho, A., Vocero-Akbani, A. and Dowdy, S.F. (1999)In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285: 1569-1572.
19. Schwarze, S.R., Hruska, K.A. and Dowdy, S.F. (2000)Protein transduction: unrestricted delivery into all cells? Trends Cell Biol 10: 290-295. Review.
20. Sherr, C.J. and Roberts, J.M. (1999)CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512.
21. Snyder, E.L., Meade, B.R. and Dowdy, S.F. (2003)Anti-cancer protein transduction strategies: reconstitution of p 27 tumor suppressor function. J Control Release 91: 45-51.
22. Sun, J., Marx, S.O., Chen, H.J., Poon, M., Marks, A.R. and Rabbani, L.E. (2001)Role for p27(Kip1) in vascular smooth muscle cell migration. Circulation 103: 2967-2972.
23. Tanner, F.C., Boehm, M., Akyurek, L.M., San, H., Yang, Z.Y., Tashiro, J.et al. (2000)Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation. Circulation 101: 2022-2025.
24. Tanner, F.C., Yang, Z.Y., Duckers, E., Gordon, D., Nabel, G.J. and Nabel, E.G. (1998)Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ Res 82: 396-403.
25. Tsui, L.V., Camrud, A., Mondesire, J., Carlson, P., Zayek, N., Camrud, L.et al. (2001)p27-p16 fusion gene inhibits angioplasty-induced neointimal hyperplasia and coronary artery occlusion. Circ Res 89: 323-328.